Alzheimer's Disease Trial

Alzheimer's Disease is an irreversible, progressive brain disorder that slowly destroys memory and thinking skills, and eventually the ability to carry out the simplest tasks. It is the most common cause of dementia, the decline in cognitive functioning which affects one in 10 people over the age of 65, and one in three people over 85. Trial treatments are aimed at temporarily relieving symptoms and slowing the rate of decline. Research has shown that medications, lifestyle choices, and therapies can all improve symptoms, slow disease progression and improve quality of life for Alzheimer's patients. Clinical trials are an important part of the process of finding and developing new treatments. By participating in clinical trials, Alzheimer's patients and their families in the medical community can help create a better future for themselves and others.